Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFeeling light-headed on Mounjaro is real, fairly common, and in most cases straightforward to manage. Tirzepatide affects how your body handles blood sugar, appetite and fluid intake, and any of those changes can briefly reduce blood flow to the head. It is not a sign the medicine is failing — but it does deserve attention. These are prescription-only medicines, and a prescriber who knows your full picture is the right person to help you work out the cause.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common assumption our prescribers hear (a question that comes up most weeks) is that light-headedness on Mounjaro simply means you're not eating enough. Sometimes that's part of it, but the full picture is usually more specific. Tirzepatide acts on two gut-hormone receptors, which slows how quickly your stomach empties and reduces appetite noticeably. Those effects ripple out in ways that aren't always obvious.
Three distinct mechanisms account for most cases of feeling light-headed on Mounjaro. First, dehydration: appetite suppression means you eat and drink less overall, and people frequently forget that a large proportion of daily fluid normally comes from food. Second, blood sugar shifts: even in people without diabetes, tirzepatide can nudge glucose levels lower than usual after meals, and a mild dip is enough to bring on dizziness or a fuzzy head. Third, a transient drop in blood pressure, particularly when standing up quickly, which becomes more likely if you are also on antihypertensives. Knowing which of these applies to you changes what you should actually do about it. You can read more about how tirzepatide works and its broader side-effect profile on our tirzepatide overview page.
The NHS medicines page for tirzepatide lists dizziness among the side effects that affect some people, particularly during the early weeks or after a dose step up.
Dehydration is the cause that catches people most off guard. When nausea cuts your appetite, you naturally eat and drink less. Many patients do not realise how much of their usual fluid intake came from food (soups, fruit, yoghurt) until those things disappear from their plate. A small fluid deficit is enough to lower blood pressure slightly and produce that familiar woozy feeling when you stand up or move quickly.
The practical response is mundane but effective: sip water steadily across the day rather than drinking large amounts in one go (which can worsen nausea). Electrolyte-containing fluids (diluted juice, a light broth) can help if plain water feels unappealing. Caffeine in large quantities can compound dehydration, so it is worth being aware of that too.
Low blood sugar after meals is less intuitive because Mounjaro is not primarily marketed as a glucose-lowering medicine for people without diabetes. Still, the hormone pathways it activates do influence insulin response. A drop in blood sugar can produce light-headedness, shakiness, or feeling suddenly cold and clammy. Eating small, regular amounts (particularly foods with some protein and complex carbohydrate) tends to smooth out those post-meal dips. If you are on any other diabetes medication alongside tirzepatide, the interaction risk is higher and your prescriber should be aware. You can find further detail on managing costs and planning treatment sustainably on our Mounjaro cost page.
If you want a closer look at why this happens and what to expect, our page on Mounjaro lightheaded symptoms covers the timing and triggers in more detail, including how dose increases affect things. Both represent a period when your body is recalibrating. After a dose step up, the gastric-slowing effect intensifies briefly, eating patterns shift again, and any blood-pressure or blood-sugar effects tend to be at their most pronounced before a new equilibrium settles in.
For people who take medicines to lower blood pressure, this window matters. If tirzepatide is reducing your weight meaningfully, your blood pressure may fall more than expected, and a dose of antihypertensive that was right six weeks ago may now be running slightly too high for your current physiology. That is not a reason to stop either medicine; it is a reason to flag the symptom to your prescriber so they can review.
Postural hypotension (the specific sensation of going light-headed when you stand up quickly) is the clearest signal that blood pressure is involved rather than blood sugar. Standing slowly, pausing at the edge of the bed or chair before rising, and staying well hydrated tend to help. If the symptom is happening unpredictably or does not improve within a couple of weeks, that conversation with your prescriber should happen sooner rather than later. Our clinical team at nume... our clinical team at the prescribers who review consultations at nume take these kinds of follow-up concerns seriously, and aftercare is part of what the service includes. You can also find a broader summary of how Mounjaro affects the body on the Mounjaro overview page.
Most light-headedness on tirzepatide is an inconvenience. Some is not. There are patterns that warrant urgent medical attention rather than a glass of water and a sit-down.
Get help promptly if dizziness comes on suddenly and severely, if it is accompanied by chest pain, shortness of breath, palpitations or a one-sided weakness, or if you actually faint. Those combinations point to causes that need proper assessment quickly. Similarly, if severe stomach pain develops (particularly pain that spreads to your back and does not settle) that could indicate pancreatitis, a serious but uncommon side effect that the MHRA has highlighted across GLP-1 medicines. The MHRA's Yellow Card service allows patients to report unexpected or serious side effects directly, and it is worth knowing that route exists.
Milder dizziness that persists beyond the first couple of weeks, that keeps returning even when you are hydrated and eating regularly, or that feels qualitatively different from anything described above, is also worth raising, not dismissing. Some people find that a different injection timing or a slower dose escalation helps, and our guide to blue light Mounjaro access explains options that may be available if you need to adjust your treatment pathway. Neither answer comes from waiting quietly. If you are concerned and looking for support, our free consultation page is the right starting point.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.